Posts Tagged 'liquid biopsy'
Cancer Statistics, History of Blood Cancer, and the Role of Biobanking
Introduction According to the World Health Organization (WHO), cancer accounted for nearly 10 million deaths worldwide in 2020 alone.1 This devastating disease can affect any part of the body, occurring when abnormal cells become dysregulated and begin to grow and spread uncontrollably. However, to fully recognize its burden and succeed in cancer research, we must…
Read MoreTargeting the TME and Its Role in Cancer Development and Drug Resistance
The Tumor Microenvironment (TME) is the complex, heterogeneous cellular environment surrounding a tumor. The TME contains immune and inflammatory cells, blood vessels, fibroblasts and myofibroblasts, extracellular matrix (ECM), and a vast array of signaling molecules 1. The dynamic interactions between tumor cells and the TME largely determine whether the primary tumor metastasizes (develops secondary…
Read MoreAACR 2023 Annual Meeting Summary Report and Highlights
The American Association for Cancer Research (AACR) held its 2023 Annual Meeting themed, Advancing The Frontiers of Cancer Science and Medicine, from April 14 – 19 in Orlando, Florida, and it was a resounding success. Our Audubon Bioscience conference team was honored to exhibit for the second time in a row at this meeting and…
Read MorePeripheral Blood Processing – Discover The Universe Within a Blood Tube
The term peripheral blood corresponds to all the blood circulating through the body’s blood vessel system and not concentrated within a specific organ (e.g. liver, spleen). Peripheral blood processing and analysis is a routine in clinical practice. However, the increasing number of translational research and life-saving therapies based on blood analysis, biobanking manipulation, and transfusion…
Read MoreHow Cancer Research Depends on Biospecimens?
March 16, 2021 Over the last two decades, oncology research has achieved outstanding results in the way we understand and approach the multifaceted nature of cancer. From immuno-oncology at the forefront to targeted therapies and biomarkers identification, novel therapeutic multiplicity is impressive. Despite their diversification, these therapies have few crucial commonalities: they are targeted, personalized,…
Read More